AG
NEOS

Algert Global’s Neos Therapeutics, Inc NEOS Stock Holding History

Algert Global’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,304
Closed -$8K – 521
2020
Q2 		$8K Sell
11,304
-11,720
-51% -$9.29K ﹤0.01% 411
2020
Q1 		$17K Sell
23,024
-11,230
-33% -$15.4K 0.01% 401
2019
Q4 		$52K Sell
34,254
-37,981
-53% -$57K 0.02% 362
2019
Q3 		$107K Sell
72,235
-5,610
-7% -$9.08K 0.04% 323
2019
Q2 		$100K Buy
+77,845
New +$143K 0.04% 319

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Algert Global's NEOS Position: Q3 2020 in Review

Algert Global sold out of Neos Therapeutics, Inc (NEOS) in Q3 2020, closing a stake of 11,304 shares — an estimated $8K sold.

Algert Global first reported a position in NEOS in Q2 2019 and held it in 5 quarters. The position peaked at $107K in Q3 2019. 41 funds tracked by Wall St. Rank hold NEOS as of Q3 2020.

  • Algert Global reported no remaining Neos Therapeutics, Inc position as of Q3 2020 after selling out during the quarter.
  • Algert Global sold 11,304 Neos Therapeutics, Inc shares in Q3 2020, an estimated $8K.
  • Algert Global first reported a position in Neos Therapeutics, Inc in Q2 2019 and held it in 5 quarters.
  • Algert Global's Neos Therapeutics, Inc position peaked at $107K in Q3 2019.
  • 41 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2020.

Based on Algert Global's 13F filing for Q3 2020, filed 16 Nov 2020.